Hongsi Jiang - Publications

Affiliations: 
Astellas Pharma 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Shin MH, Song GW, Lee SG, Hwang S, Kim KH, Ahn CS, Moon DB, Ha TY, Jung DH, Park GC, Yun YI, Kim WJ, Kang WH, Kim SH, Jiang H, et al. Once-daily, prolonged-release tacrolimus versus twice-daily, immediate-release tacrolimus in de novo living-donor liver transplantation: a Phase 4, randomized, open-label, comparative, single-center study. Clinical Transplantation. e13376. PMID 30098071 DOI: 10.1111/ctr.13376  0.336
2015 Nakanishi T, Xu X, Wynn C, Yamada T, Pan F, Erickson L, Teo H, Nakagawa T, Masunaga T, Abe J, Akamatsu M, Tamura K, Jiang H. Absence of Activation-Induced Cytidine Deaminase, a Regulator of Class Switch Recombination and Hypermutation in B Cells, Suppresses Aorta Allograft Vasculopathy in Mice. Transplantation. PMID 25769064 DOI: 10.1097/Tp.0000000000000688  0.59
2012 Erickson L, Wynn C, Pan F, Crews G, Xia G, Yamada T, Xu X, Tu Y, Huang D, Song Y, Tamura K, Jiang H. Microarray gene expression profiling of chronic allograft nephropathy in the rat kidney transplant model. Transplant Immunology. 27: 75-82. PMID 22732363 DOI: 10.1016/J.Trim.2012.06.007  0.588
2010 Cho KS, Yamada T, Wynn C, Behanna HA, Hong IC, Manaves V, Nakanishi T, Hirose J, Abe Y, Jiang H, Tamura K, Saita Y. Mechanism analysis of long-term graft survival by monocarboxylate transporter-1 inhibition. Transplantation. 90: 1299-306. PMID 21076380 DOI: 10.1097/Tp.0B013E3181Ff8818  0.382
2008 Ren YR, Pan F, Parvez S, Fleig A, Chong CR, Xu J, Dang Y, Zhang J, Jiang H, Penner R, Liu JO. Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes. Plos One. 3: e4009. PMID 19104661 DOI: 10.1371/Journal.Pone.0004009  0.45
2008 Jang MS, Pan F, Erickson LM, Fisniku O, Crews G, Wynn C, Hong IC, Tamura K, Kobayashi M, Jiang H. A blocking anti-CD28-specific antibody induces long-term heart allograft survival by suppression of the PKC theta-JNK signal pathway. Transplantation. 85: 1051-5. PMID 18408588 DOI: 10.1097/Tp.0B013E31816846F6  0.592
2005 Jiang H, Pan F, Erickson LM, Jang MS, Sanui T, Kunisaki Y, Sasazuki T, Kobayashi M, Fukui Y. Deletion of DOCK2, a regulator of the actin cytoskeleton in lymphocytes, suppresses cardiac allograft rejection. The Journal of Experimental Medicine. 202: 1121-30. PMID 16230477 DOI: 10.1084/Jem.20050911  0.653
2004 Erickson L, Crews G, Pan F, Fisniku O, Jang MS, Wynn C, Kobayashi M, Jiang H. Unique gene expression profiles of heart allograft rejection in the interferon regulatory factor-1-deficient mouse. Transplant Immunology. 13: 169-75. PMID 15381199 DOI: 10.1016/j.trim.2004.06.003  0.559
2003 Erickson LM, Pan F, Ebbs A, Kobayashi M, Jiang H. Microarray-based gene expression profiles of allograft rejection and immunosuppression in the rat heart transplantation model. Transplantation. 76: 582-8. PMID 12923448 DOI: 10.1097/01.Tp.0000081398.65568.1B  0.588
2002 Jiang H, Wynn C, Pan F, Ebbs A, Erickson LM, Kobayashi M. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production. Transplantation. 73: 1808-17. PMID 12085006 DOI: 10.1097/00007890-200206150-00019  0.586
1999 Jiang H, Sakuma S, Fujii Y, Akiyama Y, Ogawa T, Tamura K, Kobayashi M, Fujitsu T. Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival. Transplant International. 12: 92-99. PMID 10363590 DOI: 10.1007/S001470050192  0.348
Show low-probability matches.